| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 680 | 0 | 2.867 | 4.431 | 30.514 | 127.670 |
| Total Income - EUR | - | - | - | - | 680 | 0 | 2.867 | 4.431 | 30.524 | 128.046 |
| Total Expenses - EUR | - | - | - | - | 659 | 387 | 2.026 | 3.319 | 7.205 | 22.205 |
| Gross Profit/Loss - EUR | - | - | - | - | 21 | -387 | 841 | 1.112 | 23.318 | 105.841 |
| Net Profit/Loss - EUR | - | - | - | - | 0 | -387 | 755 | 981 | 19.634 | 89.597 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Oncopal S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 24.023 | 19.199 |
| Current Assets | - | - | - | - | 299 | 16 | 999 | 2.144 | 15.087 | 93.358 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 12.393 | 70.375 |
| Cash | - | - | - | - | 299 | 16 | 999 | 2.144 | 2.694 | 22.983 |
| Shareholders Funds | - | - | - | - | 43 | -345 | 417 | 1.030 | 19.683 | 89.645 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 257 | 361 | 582 | 1.114 | 19.427 | 22.912 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncopal S.r.l.